Karina Ovejero‐Paredes

Karina Ovejero‐Paredes

Auto-generated profile, based on publicly available information

Karina Ovejero‐Paredes

Department of Engineering, Università Campus Bio-Medico di Roma, Rome, ITALY

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2023 in Chemistry – A European Journal
Verified
Journal Article
Open access
I. Jénnifer GómezI. Jénnifer Gómez
I. Jénnifer Gómez
KOKarina Ovejero‐Paredes
Karina Ovejero‐Paredes
Jose M Mendez-ArriagaJose M Mendez-Arriaga
Jose M Mendez-Arriaga
NPNada Pizurova
Nada Pizurova
Marco FiliceMarco Filice
Marco Filice
Santiago Gomez-RuizSantiago Gomez-Ruiz
Santiago Gomez-Ruiz
The pharmacological activity of organotin(IV) complexes in cancer therapy is well recognized but their large applicability is hampered by their poor water solubility. Hence, carbon dots, in particular nitrogen‐doped graphene quantum dots (NGQDs), may be a promising alternative for the efficient delivery of organotin(IV) compounds as they have a substantial aqueous solubility, a good chemical stability, and non‐toxicity as well as a bright photoluminescence that make them ideal for theranostic applications against cancer. Two different multifunctional nanosystems have been synthesized and fully characterized based on two fragments of organotin‐based cytotoxic compounds and 4‐formylbenzoic acid (FBA), covalently grafted onto the NGQDs surface. Subsequently, an in vitro determination of the therapeutic and theranostic potential of the achieved multifunctional systems was carried out. The results showed a high cytotoxic potential of the NGQDs‐FBA‐Sn materials against breast cancer cell line (MDA‐MB‐231) and a lower effect on a non‐cancer cell line (kidney cells, HEK293T). Besides, thanks to their optical properties, the dots enabled their fluorescence molecular imaging in the cytoplasmatic region of the cells pointing towards a successful cellular uptake and a release of the metallodrug inside cancer cells (NGQDs‐FBA‐Sn).

23 July 2025 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
KOKarina Ovejero-Paredes
Karina Ovejero-Paredes
Giovanni BisbanoGiovanni Bisbano
Giovanni Bisbano
IFInge Flier
Inge Flier
AGAlejandro González-Simón
Alejandro González-Simón
Marzia MarcielloMarzia Marciello
Marzia Marciello
Marco FiliceMarco Filice
Marco Filice
Triple negative breast cancer (TNBC) represents one of the most aggressive types of cancer, with a difficult treatment leading to poor prognosis of the disease. Herein we report the synthesis of a custom-made cyclic RGD peptide (cRGD), and its use in decorating liposomes for targeted drug delivery of doxorubicin to TNBC cells overexpressing integrin receptor αvβ3. Liposomes carrying dibenzocyclooctine groups on their surface were produced using an optimized large scale microfluidic-assisted approach and subsequently conjugated with cRGD bearing an acyl azide group by means of a click chemistry reaction. This functionalization promotes enhanced cellular uptake via integrin-mediated endocytosis. In vitro assessments confirm enhanced selectivity and cytotoxicity of cRGD-liposomes against triple-negative cancer cells, in addition to dual imaging capabilities by fluorescence and magnetic resonance techniques due to the incorporation of a fluorescent dye and gadolinium complex, respectively. These features support the potential of cRGD-liposomes as a promising platform for targeted drug delivery to specific cancer cell populations, establishing them as viable theranostic agents for precision medicine applications.

21 April 2024 in Applied Organometallic Chemistry
Verified
Journal Article
Open access
MIMichael Aondona Iorhemba
Michael Aondona Iorhemba
KOKarina Ovejero‐Paredes
Karina Ovejero‐Paredes
DDDiana Díaz
Diana Díaz
VAVictoria García Almodóvar
Victoria García Almodóvar
SISulaiman Ola Idris
Sulaiman Ola Idris
Santiago Gomez-RuizSantiago Gomez-Ruiz
Santiago Gomez-Ruiz
Nanostructured materials possess promising potential for cancer therapy through precise adjustment of their functionalization and physicochemical attributes. This study primarily focuses on the synthesis and characterization of mesoporous silica nanoparticles (MSN) that are functionalized with titanocene dichloride (a therapeutic agent) and one of several amino acids—cysteine, captopril, penicillamine, or methionine—utilizing 3‐aminopropyltriethoxysilane (AP) as a linker. This synthesis yielded four innovative metallodrug‐functionalized nanostructured materials (MSN‐AP‐Cys‐Ti, MSN‐AP‐Cap‐Ti, MSN‐AP‐Pen‐Ti, and MSN‐AP‐Met‐Ti), meticulously characterized using diverse analytical techniques such as X‐ray diffraction (XRD), X‐ray fluorescence (XRF), diffuse reflectance ultraviolet–visible (DR UV–Vis), Fourier transform infrared (FTIR), solid‐state nuclear magnetic resonance (NMR) spectroscopy, and transmission electron microscopy (TEM). The textural properties of the nanomaterials post‐functionalization displayed slight modifications, confirming the successful integration of the therapeutic agents. Evaluation of cytotoxicity in the breast cancer cell line MDA‐MB‐231, with the healthy cell line Hek‐293T as control via MTT assays, revealed the active nature of the functionalized silica‐based materials. The viability of both cell lines indicated a concentration‐dependent response to the materials. Among the tested systems, cysteine and captopril exhibited the highest activity concerning IC50relative to material concentration. The enhanced biological activity of higher functionalized nanosystems suggests a favorable cell internalization facilitated by the amino acid fragment. Additionally, qualitative DNA binding studies hinted at potential DNA adsorption on the surface of the metallodrug‐functionalized nanomaterials, forming DNA adducts where a strand of DNA covalently bonds to the metallodrug moiety. This was deduced from the hypsochromic shift in absorbance of the characteristic π–π* andn–π* transitions in DNA, which occurred from 1.01 to 0.76 and 1.26–0.19 following drug (MSN‐AP‐Cap‐Ti) interaction.

6 March 2024 in Biomedical Materials
Verified
Journal Article
Open access
PDF file
MIMichael Aondona Iorhemba
Michael Aondona Iorhemba
JAJavier Alvarez-Conde
Javier Alvarez-Conde
DDDiana Díaz
Diana Díaz
Jose M Mendez-ArriagaJose M Mendez-Arriaga
Jose M Mendez-Arriaga
VAVictoria García Almodóvar
Victoria García Almodóvar
Santiago Gomez-RuizSantiago Gomez-Ruiz
Santiago Gomez-Ruiz
Nanoscale materials have demonstrated a very high potential in anticancer therapy by properly adjusting their functionalization and physicochemical properties. Herein, we report the synthesis of some novel vanadocene-loaded silica-based nanomaterials incorporating four different S-containing amino acids (penicillamine, methionine, captopril, and cysteine) and different fluorophores (rhodamine B, coumarin 343 or Alexa Fluor™ 647), which have been characterized by diverse solid-state spectroscopic techniques viz; FTIR, diffuse reflectance spectroscopies, 13C and 51V solid-state NMR spectroscopy, thermogravimetry and TEM. The analysis of the biological activity of the novel vanadocene-based nanostructured silicas showed that the materials containing cysteine and captopril aminoacids demonstrated high cytotoxicity and selectivity against triple negative breast cancer cells, making them very promising antineoplastic drug candidates. According to the biological results it seems that vanadium activity is connected to its incorporation through the amino acid, resulting in synergy that increases the cytotoxic activity against cancer cells of the studied materials presumably by increasing cell internalization. The results presented herein hold significant potential for future developments in mesoporous silica-supported metallodrugs, which exhibit strong cytotoxicity while maintaining low metal loading. They also show potential for theranostic applications highlighted by the analysis of the optical properties of the studied systems after incorporating rhodamine B, coumarin 343 (possible) in vitro anticancer analysis, or Alexa Fluor™ 647 (in vivo studies of cancer models).

11 July 2024 in Advanced Therapeutics
Verified
Journal Article
Open access
VAVictoria García Almodóvar
Victoria García Almodóvar
KOKarina Ovejero‐Paredes
Karina Ovejero‐Paredes
DDDiana Díaz
Diana Díaz
Jose M Mendez-ArriagaJose M Mendez-Arriaga
Jose M Mendez-Arriaga
SPSanjiv Prashar
Sanjiv Prashar
Santiago Gomez-RuizSantiago Gomez-Ruiz
Santiago Gomez-Ruiz
The current search for more effective and milder cancer treatments has led to the development of a wide variety of multifunctional nanoplatforms that are designed to both diagnose and treat cancer. In this study, the optimization of the synthesis of theranostic materials based on mesoporous silica nanoparticles (MSNs) functionalized with different cytotoxic (organotin(IV) compounds), imaging (fluorescein and/or indocyanine green), and targeting agents of interest, such as albumin (HA), is achieved by using different strategies. These systems shows good cytotoxic capacity against triple negative breast cancer (TNBC) cells (MDA‐MB‐231) in MTT (dimethylthiazolyl‐diphenyl‐tetrazolium bromide) assays and confocal analysis shows that the incorporation of HA as a potential active targeting molecule may enhance the cellular uptake of the nanomaterial, and thus, increasing its therapeutic potential. The analysis of the results and the effect of the imaging, targeting, and cytotoxic fragments should allow a more in‐depth study of these materials in other in vitro and/or in vivo models.

14 January 2022
Verified
Book Chapter
Closed access
Marzia MarcielloMarzia Marciello
Marzia Marciello
YMYurena Luengo Morato
Yurena Luengo Morato
KPKarina Ovejero Paredes
Karina Ovejero Paredes
LCLaura Lozano Chamizo
Laura Lozano Chamizo
Marco FiliceMarco Filice
Marco Filice